Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Role of TLR4 in the gut-brain axis in Parkinson's disease: A translational study from men to mice

Open access

Abstract

Objective: Recent evidence suggesting an important role of gut-derived inflammation in brain disorders has opened up new directions to explore the possible role of the gut-brain axis in neurodegenerative diseases. Given the prominence of dysbiosis and colonic dysfunction in patients with Parkinson’s disease (PD), we propose that toll-like receptor 4 (TLR4)-mediated intestinal dysfunction could contribute to intestinal and central inflammation in PD-related neurodegeneration. Design: To test this hypothesis we performed studies in both human tissue and a murine model of PD. Inflammation, immune activation and microbiota composition were measured in colonic samples from subjects with PD and healthy controls subjects and rotenone or vehicle-treated mice. To further assess the role of the TLR4 signalling in PD-induced neuroinflammation, we used TLR4-knockout (KO) mice in conjunction with oral rotenone administration to model PD. Results: Patients with PD have intestinal barrier disruption, enhanced markers of microbial translocation and higher pro-inflammatory gene profiles in the colonic biopsy samples compared with controls. In this regard, we found increased expression of the bacterial endotoxin-specific ligand TLR4, CD3+ T cells, cytokine expression in colonic biopsies, dysbiosis characterised by a decrease abundance of SCFA-producing colonic bacteria in subjects with PD. Rotenone treatment in TLR4-KO mice revealed less intestinal inflammation, intestinal and motor dysfunction, neuroinflammation and neurodegeneration, relative to rotenone-treated wild-type animals despite the presence of dysbiotic microbiota in TLR4-KO mice. Conclusion: Taken together, these studies suggest that TLR4-mediated inflammation plays an important role in intestinal and/or brain inflammation, which may be one of the key factors leading to neurodegeneration in PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2018-316844

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Patients with Parkinson's disease (PD) show increased colonic permeability and associated colonic inflammatory as well as immune markers in their biopsies compared with healthy controls (HC). (A) Per cent excretion of sucralose in the urine samples as an intestinal permeability marker. (B) Levels of LPS-binding protein (LBP) as a marker for systemic endotoxin in plasma samples. (C) Photomicrographs of immunofluorescence staining of tight junction protein zonula occludens 1 (ZO-1) in HC (a, b) and PD (c, d) colonic mucosa. (D) Integrity scoring for ZO-1 tight junction protein expression in colonic samples. (E) Photomicrographs of stained toll-like receptor 4 (TLR4)+ cells in lamina propria of the HC (a, b) and PD mucosa (c, d). (G) Photomicrographs of stained CD3+ T cells in colonic mucosa of HC (a, b) and PD (c, d). (H) Assessment of CD3+ cells in lamina propria of colonic samples. Scale bars: C(c)=50 µm and C(d)=20 µm, E(c)=75 µm and E(d)=25 µm, G(c)=40 µm and G(d)=25 µm. *P<0.05, **p<0.001, ***p<0.0001. Data represent mean±SEM.
Figure 1 Patients with Parkinson's disease (PD) show increased colonic permeability and associated colonic inflammatory as well as immune markers in their biopsies compared with healthy controls (HC). (A) Per cent excretion of sucralose in the urine samples as an intestinal permeability marker. (B) Levels of LPS-binding protein (LBP) as a marker for systemic endotoxin in plasma samples. (C) Photomicrographs of immunofluorescence staining of tight junction protein zonula occludens 1 (ZO-1) in HC (a, b) and PD (c, d) colonic mucosa. (D) Integrity scoring for ZO-1 tight junction protein expression in colonic samples. (E) Photomicrographs of stained toll-like receptor 4 (TLR4)+ cells in lamina propria of the HC (a, b) and PD mucosa (c, d). (G) Photomicrographs of stained CD3+ T cells in colonic mucosa of HC (a, b) and PD (c, d). (H) Assessment of CD3+ cells in lamina propria of colonic samples. Scale bars: C(c)=50 µm and C(d)=20 µm, E(c)=75 µm and E(d)=25 µm, G(c)=40 µm and G(d)=25 µm. *P<0.05, **p<0.001, ***p<0.0001. Data represent mean±SEM.CC-BY-NC · From the PDF
Figure 2 Higher pro-inflammatory milieu was observed in the colonic biopsies of subjects with Parkinson's disease (PD) compared with healthy control (HC) subjects. Genes specific for microbiota-induced intestinal inflammation and gut dysfunction were evaluated from HC subjects (HC1, HC2, HC3 and HC4) and subjects with PD (PD1, PD2, PD3, PD4, PD5, PD6). *P<0.03 denotes significantly different gene in PD compared with HC. Green colour indicates lower expression and red colour indicates higher expression of gene.
Figure 2 Higher pro-inflammatory milieu was observed in the colonic biopsies of subjects with Parkinson's disease (PD) compared with healthy control (HC) subjects. Genes specific for microbiota-induced intestinal inflammation and gut dysfunction were evaluated from HC subjects (HC1, HC2, HC3 and HC4) and subjects with PD (PD1, PD2, PD3, PD4, PD5, PD6). *P<0.03 denotes significantly different gene in PD compared with HC. Green colour indicates lower expression and red colour indicates higher expression of gene.CC-BY-NC · From the PDF
Figure 3 Rotenone Parkinson's disease (PD) model recapitulates GI physiology as observed in human patients with PD and toll-like receptor 4 (TLR4)-knockout (KO) partially protects against them. (A) Colon length. (B) Intestinal transit distance. (C) Photomicrographs of immunofluorescence staining for zonula occludens 1 (ZO-1). (D) ZO-1 integrity scores. (E) Photomicrographs of TLR4 immunofluorescence staining. Graphs represent TLR4+ cell counts in (c) ileum and (f) colon samples. (F) Photomicrographs of CD3 stained cells in colonic samples. Black number sign (#) in panel (b) represent increased CD3+ T cells infiltration into lamina propria. (G) Quantitative analyses of cell counts for CD3+ T cells in lamina propria. Scale bars C(d), E(e), F(d)=100 µm. ***P<0.001, **P< 0.01, *P< 0.05. Data represent as mean+SEM.
Figure 3 Rotenone Parkinson's disease (PD) model recapitulates GI physiology as observed in human patients with PD and toll-like receptor 4 (TLR4)-knockout (KO) partially protects against them. (A) Colon length. (B) Intestinal transit distance. (C) Photomicrographs of immunofluorescence staining for zonula occludens 1 (ZO-1). (D) ZO-1 integrity scores. (E) Photomicrographs of TLR4 immunofluorescence staining. Graphs represent TLR4+ cell counts in (c) ileum and (f) colon samples. (F) Photomicrographs of CD3 stained cells in colonic samples. Black number sign (#) in panel (b) represent increased CD3+ T cells infiltration into lamina propria. (G) Quantitative analyses of cell counts for CD3+ T cells in lamina propria. Scale bars C(d), E(e), F(d)=100 µm. ***P<0.001, **P< 0.01, *P< 0.05. Data represent as mean+SEM.CC-BY-NC · From the PDF
Figure 4 Toll-like receptor 4 (TLR4)-knockout (KO) mice were partially protect against rotenone-induced enteric glial inflammation and α -syn expression in the colon. Photomicrographs represent histology for (A) GFAP and (C) α -syn markers in colon. (B) Quantitative analyses of optical density (OD) data for GFAP in myenteric plexuses and (D) OD data for α -syn expression in myenteric plexuses. Scale bars A(d), C(d)=100 µm. Scale bar in panel represents 100 µm. *P<0.05, ***p<0.0001. Data represented as mean+SEM.
Figure 4 Toll-like receptor 4 (TLR4)-knockout (KO) mice were partially protect against rotenone-induced enteric glial inflammation and α -syn expression in the colon. Photomicrographs represent histology for (A) GFAP and (C) α -syn markers in colon. (B) Quantitative analyses of optical density (OD) data for GFAP in myenteric plexuses and (D) OD data for α -syn expression in myenteric plexuses. Scale bars A(d), C(d)=100 µm. Scale bar in panel represents 100 µm. *P<0.05, ***p<0.0001. Data represented as mean+SEM.CC-BY-NC · From the PDF
Figure 5 Toll-like receptor (TLR4)-knockout (KO)-rotenone mice showed less pro-inflammatory microglia, less dopaminergic cell loss and less behaviour deficits compared with wild-type (WT)-rotenone. (A-D) Average number of branches, branches end points, branch length and the ratio cell body size/total cell size of microglia in the substantia (SN). (E) Photomicrographs of microglial cells for each condition. TLR4-KO mice showed microglia with less pro-inflammatory phenotype in the SN compared with WT-rotenone mice. (F) Photomicrographs of tyrosine hydroxylase (TH) stained dopaminergic cells. (G) Cell counts for TH stained dopaminergic cells into SN. WT-rotenone showed profound loss of TH cells while TLR4-KOrotenone showed a mitigated TH+ cell loss in the SN. ( H ) Rotarod data to assess motor function associated behaviour deficits. TLR4-KO-rotenone group showed reduced rotenone-induced motor-dysfunction compared with WT-rotenone. Scale bars: E(d)=10 µm, F(d)=200 µm. *P<0.05, **p<0.001, ***p<0.0001. Data represented as mean+SEM.
Figure 5 Toll-like receptor (TLR4)-knockout (KO)-rotenone mice showed less pro-inflammatory microglia, less dopaminergic cell loss and less behaviour deficits compared with wild-type (WT)-rotenone. (A-D) Average number of branches, branches end points, branch length and the ratio cell body size/total cell size of microglia in the substantia (SN). (E) Photomicrographs of microglial cells for each condition. TLR4-KO mice showed microglia with less pro-inflammatory phenotype in the SN compared with WT-rotenone mice. (F) Photomicrographs of tyrosine hydroxylase (TH) stained dopaminergic cells. (G) Cell counts for TH stained dopaminergic cells into SN. WT-rotenone showed profound loss of TH cells while TLR4-KOrotenone showed a mitigated TH+ cell loss in the SN. ( H ) Rotarod data to assess motor function associated behaviour deficits. TLR4-KO-rotenone group showed reduced rotenone-induced motor-dysfunction compared with WT-rotenone. Scale bars: E(d)=10 µm, F(d)=200 µm. *P<0.05, **p<0.001, ***p<0.0001. Data represented as mean+SEM.CC-BY-NC · From the PDF
Image 6
CC-BY-NC · From the PDF
(C) Firmicutes/Bacteroidetes ratio at phylum taxonomy
(C) Firmicutes/Bacteroidetes ratio at phylum taxonomyCC-BY-NC · From the PDF
Image 8
CC-BY-NC · From the PDF
(D) Cecal mucosa - relative abundance at genus taxonomy
(D) Cecal mucosa - relative abundance at genus taxonomyCC-BY-NC · From the PDF
Figure 7 Microbiome analysis assessing mice wild type (WT) or toll-like receptor 4 (TLR4)-knockout (KO) (with or without rotenone treatment). (A) Caecal sample sites were examined for alpha diversity's richness between all four mouse groups, at the taxonomic level of genus. Data expressed as mean+SEM and analysed with two-way analysis of variance (ANOVA): within the caecum mucosa, richness showed a significant rotenone treatment effect (F (1,36) =12.97, p=0.0009). Bonferroni post hoc test: **p=0.01, ***p=0.001. (B) Ordination plots (nMDS plots) of microbial community structure at the taxonomic level of genus, using analysis of similarity ANOSIM (Global R and P values shown), comparing WT-vehicle (pink triangles), WTrotenone (green triangles), TLR4-KO-vehicle (red triangles) and TLR4-KO-rotenone (blue triangle) treated mice caecum mucosa and luminal content samples. (C) Firmicutes-to-bacteriodetes (F/B) ratio comparisons between mice caecal sample sites, at the taxonomic level of phylum. Data expressed as mean+SEM and analysed with two-way ANOVA: F/B ratio in the caecal mucosa showed a significant rotenone treatment effect (F (1,35) =5.135, p=0.0297), geneotype effect (F (1,35) =9.391, p=0.0042) and interaction between rotenone and genotype effect (F (1,35) =6.149, p=0.0181). The F/B ratio in the luminal content showed a significant effect of interaction between rotenone and genotype effect (F (1,34) =5.243, p=0.0284). Bonferroni post hoc test: *p=0.05, **p=0.01, ***p=0.001. (D, E) Caecal mucosa and luminal content stacked column plots depicting the relative abundances of individual bacterial genera ( ˂ 1%); significant (FDR-p) genus taxa are bolded.
Figure 7 Microbiome analysis assessing mice wild type (WT) or toll-like receptor 4 (TLR4)-knockout (KO) (with or without rotenone treatment). (A) Caecal sample sites were examined for alpha diversity's richness between all four mouse groups, at the taxonomic level of genus. Data expressed as mean+SEM and analysed with two-way analysis of variance (ANOVA): within the caecum mucosa, richness showed a significant rotenone treatment effect (F (1,36) =12.97, p=0.0009). Bonferroni post hoc test: **p=0.01, ***p=0.001. (B) Ordination plots (nMDS plots) of microbial community structure at the taxonomic level of genus, using analysis of similarity ANOSIM (Global R and P values shown), comparing WT-vehicle (pink triangles), WTrotenone (green triangles), TLR4-KO-vehicle (red triangles) and TLR4-KO-rotenone (blue triangle) treated mice caecum mucosa and luminal content samples. (C) Firmicutes-to-bacteriodetes (F/B) ratio comparisons between mice caecal sample sites, at the taxonomic level of phylum. Data expressed as mean+SEM and analysed with two-way ANOVA: F/B ratio in the caecal mucosa showed a significant rotenone treatment effect (F (1,35) =5.135, p=0.0297), geneotype effect (F (1,35) =9.391, p=0.0042) and interaction between rotenone and genotype effect (F (1,35) =6.149, p=0.0181). The F/B ratio in the luminal content showed a significant effect of interaction between rotenone and genotype effect (F (1,34) =5.243, p=0.0284). Bonferroni post hoc test: *p=0.05, **p=0.01, ***p=0.001. (D, E) Caecal mucosa and luminal content stacked column plots depicting the relative abundances of individual bacterial genera ( ˂ 1%); significant (FDR-p) genus taxa are bolded.CC-BY-NC · From the PDF
(E) Cecal content- relative abundance at genus taxonomy
(E) Cecal content- relative abundance at genus taxonomyCC-BY-NC · From the PDF
Figure 8 Caecum mucosa differential abundances of genus taxonomic level operational taxonomic units (OTU). (A) The number of significantly increased relative abundant genus taxa (FDR-p), per mouse caecal mucosa group. Volcano plot of estimated log2 fold change (FC) differences in genus (OTU) abundance between: effect of rotenone, (B) wild-type (WT)-vehicle vs WT-rotenoneand toll-like receptor 4 (TLR4)-knockout (KO)-vehicle vs TLR4KO-rotenone; effect of TLR4-KO genotype, (C) WT-vehicle vs TLR4-KO-vehicleand WT-rotenone vs TLR4-KO rotenone, with corresponding BenjaminiHochberg adjusted FDR-p values (q), derived from Kruskal-Wallis test in R programing language. The red dotted line indicates the 5% false discovery threshold. Prevalence indicates percentage of mice groups in which a given genus OTU is present. Abundance indicates mean relative abundance (%) of a given genus OTU. Name of genus OTUs differentially abundant at FDR≤5% are given at the lowest classified rank in Greengenes (Greengenes ID). The parameter log2FC was calculated for each mouse group according to the formula log2FC=log2(mean intervention/mean control). o, order; f, family; g, genus.
Figure 8 Caecum mucosa differential abundances of genus taxonomic level operational taxonomic units (OTU). (A) The number of significantly increased relative abundant genus taxa (FDR-p), per mouse caecal mucosa group. Volcano plot of estimated log2 fold change (FC) differences in genus (OTU) abundance between: effect of rotenone, (B) wild-type (WT)-vehicle vs WT-rotenoneand toll-like receptor 4 (TLR4)-knockout (KO)-vehicle vs TLR4KO-rotenone; effect of TLR4-KO genotype, (C) WT-vehicle vs TLR4-KO-vehicleand WT-rotenone vs TLR4-KO rotenone, with corresponding BenjaminiHochberg adjusted FDR-p values (q), derived from Kruskal-Wallis test in R programing language. The red dotted line indicates the 5% false discovery threshold. Prevalence indicates percentage of mice groups in which a given genus OTU is present. Abundance indicates mean relative abundance (%) of a given genus OTU. Name of genus OTUs differentially abundant at FDR≤5% are given at the lowest classified rank in Greengenes (Greengenes ID). The parameter log2FC was calculated for each mouse group according to the formula log2FC=log2(mean intervention/mean control). o, order; f, family; g, genus.CC-BY-NC · From the PDF
Figure 9 Caecum luminal content differential abundances of genus taxonomic level operational taxonomic units (OTU). (A) The number of significantly increased relative abundant genus taxa (FDR-p), per mouse caecal luminal content group. Volcano plot of estimated log2 fold change (FC) differences in genus (OTU) abundance between: effect of rotenone, (B) wild-type (WT)-vehicle vs WT-rotenone and toll-like receptor 4 (TLR4)-knockout (KO)-vehicle vs TLR4-KO-rotenone; effect of TLR4-KO genotype (C)WT-vehicle vs TLR4-KO-vehicle, (E) WT-rotenone vs TLR4-KO rotenone, with corresponding Benjamini-Hochberg adjusted FDR-p values (q), derived from Kruskal-Wallis test in R programing language. The red dotted line indicates the 5% false discovery threshold. Prevalence indicates percentage of mice groups in which a given genus OTU is present. Abundance indicates mean relative abundance (%) of a given genus OTU. Name of genus OTUs differentially abundant at FDR≤5% are given at the lowest classified rank in Greengenes (Greengenes ID). The parameter log2FC was calculated for each mouse group according to the formula log2FC=log2(mean intervention/mean control). o, order; f, family; g, genus.
Figure 9 Caecum luminal content differential abundances of genus taxonomic level operational taxonomic units (OTU). (A) The number of significantly increased relative abundant genus taxa (FDR-p), per mouse caecal luminal content group. Volcano plot of estimated log2 fold change (FC) differences in genus (OTU) abundance between: effect of rotenone, (B) wild-type (WT)-vehicle vs WT-rotenone and toll-like receptor 4 (TLR4)-knockout (KO)-vehicle vs TLR4-KO-rotenone; effect of TLR4-KO genotype (C)WT-vehicle vs TLR4-KO-vehicle, (E) WT-rotenone vs TLR4-KO rotenone, with corresponding Benjamini-Hochberg adjusted FDR-p values (q), derived from Kruskal-Wallis test in R programing language. The red dotted line indicates the 5% false discovery threshold. Prevalence indicates percentage of mice groups in which a given genus OTU is present. Abundance indicates mean relative abundance (%) of a given genus OTU. Name of genus OTUs differentially abundant at FDR≤5% are given at the lowest classified rank in Greengenes (Greengenes ID). The parameter log2FC was calculated for each mouse group according to the formula log2FC=log2(mean intervention/mean control). o, order; f, family; g, genus.CC-BY-NC · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

8 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 59 references

Research works printed but not linked: 1

  1. 10.1007/s10517-017-3700-7 · DOI · Paper page

Cited by

See all 468

Metadata

Authors
Perez-Pardo, P., Dodiya, H. B., Engen, P. A., Forsyth, C. B., Huschens, A. M., Shaikh, M., Voigt, R. M., Naqib, A., Green, S. J., Kordower, J. H., Shannon, K. M., Garssen, J., Kraneveld, A. D., & Keshavarzian, A.
Affiliations
  • Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands
  • Rush University Medical Center (US)
  • Utrecht University (NL)
  • University of Illinois Chicago (US)
  • Rush University (US)
Venue
Gut
Publisher
BMJ
Published
2018-12-15
Volume
68
Issue
5
Pages
829-843
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2905177566
Cited by
467
References
59
Citations by year
2026: 36 · 2025: 52 · 2024: 72 · 2023: 68 · 2022: 75 · 2021: 93 · 2020: 45 · 2019: 24
FWCI
27.68
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Gut (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • HighWire Press Open Archive (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, cc-by-nc)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
Parkinson's disease, TLR4, gut-brain axis, neuroinflammation, gut dysbiosis, intestinal barrier dysfunction, microbial translocation, short-chain fatty acids, rotenone, TLR4 knockout mice, colonic inflammation, motor impairment, neurodegeneration, gut microbiota
MeSH terms
Animals, Colon, Disease Models, Animal, Humans, Mice, Inbred C57BL, Parkinson Disease, Case-Control Studies, CD3 Complex, Mice, Knockout, Toll-Like Receptor 4, Mice, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of TLR4 in the gut-brain axis in Parkinson's disease: A translational study from men to mice. https://app.cochat.ai/papers/10.1136/gutjnl-2018-316844
The paper
Perez-Pardo, P., Dodiya, H. B., Engen, P. A., Forsyth, C. B., Huschens, A. M., Shaikh, M., Voigt, R. M., Naqib, A., Green, S. J., Kordower, J. H., Shannon, K. M., Garssen, J., Kraneveld, A. D., & Keshavarzian, A. (2019). Role of TLR4 in the gut-brain axis in Parkinson's disease: A translational study from men to mice. Gut. https://doi.org/10.1136/gutjnl-2018-316844

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.